 The potential benefits of Irinotecan Bead could be significant since a sustainable release of chemotherapy over time could have a greater effect on tumor mass, because optimal therapeutic efficacy of Irinotecan an S phase-specific cytotoxic drug generally requires prolonged exposure of the tumor to concentrations exceeding a minimum threshold. 